Juliane K. Mueller

Heinrich Hoffmann Str. 10
Frankfurt Am Main, HE 60528, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

Journal: EMBO reports

Published: October 29, 2025

Effectiveness of a communal, multilevel, interdisciplinary suicide prevention program.

Effectiveness of a communal, multilevel, interdisciplinary suicide prevention program.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: July 16, 2025

Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors.

Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors.

Journal: Nature communications

Published: July 03, 2025

Workflow for E3 Ligase Ligand Validation for PROTAC Development.

Workflow for E3 Ligase Ligand Validation for PROTAC Development.

Journal: ACS chemical biology

Published: February 11, 2025

Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.

Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.

Journal: Journal of medicinal chemistry

Published: December 27, 2024

Unmasking the Psychological Landscape of Long COVID: A Cluster-analytical Approach.

Unmasking the Psychological Landscape of Long COVID: A Cluster-analytical Approach.

Journal: Biopsychosocial science and medicine

Published: April 29, 2024

Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.

Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.

Journal: BMJ mental health

Published: February 06, 2024

Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.

Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: December 10, 2023

Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey.

Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey.

Journal: Pharmacopsychiatry

Published: November 09, 2023

Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?

Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?

Journal: Pharmacopsychiatry

Published: January 26, 2022

Changes in the pattern of suicides and suicide attempt admissions in relation to the COVID-19 pandemic.

Changes in the pattern of suicides and suicide attempt admissions in relation to the COVID-19 pandemic.

Journal: European archives of psychiatry and clinical neuroscience

Published: December 12, 2021

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.

Journal: Frontiers in psychiatry

Published: January 16, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026